Cargando…

IKKβ Kinase Promotes Stemness, Migration, and Invasion in KRAS-Driven Lung Adenocarcinoma Cells

KRAS oncogenic mutations are widespread in lung cancer and, because direct targeting of KRAS has proven to be challenging, KRAS-driven cancers lack effective therapies. One alternative strategy for developing KRAS targeted therapies is to identify downstream targets involved in promoting important m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodrigues, Felipe Silva, Miranda, Vanessa Silva, Carneiro-Lobo, Tatiana Correa, Scalabrini, Luiza Coimbra, Kruspig, Björn, Levantini, Elena, Murphy, Daniel J., Bassères, Daniela Sanchez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460870/ https://www.ncbi.nlm.nih.gov/pubmed/32823550 http://dx.doi.org/10.3390/ijms21165806

Ejemplares similares

Aurora kinase targeting in lung cancer reduces KRAS-induced transformation
por: dos Santos, Edmilson Ozorio, et al.
Publicado: (2016)

Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma
por: Neidler, Sarah, et al.
Publicado: (2019)

IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity
por: Bassères, Daniela S., et al.
Publicado: (2014)

IKKα inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways
por: Song, Na-Young, et al.
Publicado: (2018)

Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
por: Pan, Jing, et al.
Publicado: (2017)

UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma
por: Kostyrko, Kaja, et al.
Publicado: (2023)

KRAS-Driven Lung Adenocarcinoma and B Cell Infiltration: Novel Insights for Immunotherapy
por: Rosamaria, Pinto, et al.
Publicado: (2019)

Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma
por: Wang, Yanxiao, et al.
Publicado: (2017)

KRAS and EGFR mutations coexisting in lung adenocarcinoma
por: Sousa, Vitor, et al.
Publicado: (2010)

KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapy
por: Ambrogio, Chiara, et al.
Publicado: (2016)

Non-Oncogene Addiction of KRAS-Mutant Cancers to IL-1β via Versican and Mononuclear IKKβ
por: Spella, Magda, et al.
Publicado: (2023)

FAM111B enhances proliferation of KRAS‐driven lung adenocarcinoma by degrading p16
por: Kawasaki, Keisuke, et al.
Publicado: (2020)

A mouse model for the study of anti-tumor T cell responses in Kras-driven lung adenocarcinoma
por: Fitzgerald, Brittany, et al.
Publicado: (2021)

IKKβ inhibitor identification: a multi-filter driven novel scaffold
por: Nagarajan, Shanthi, et al.
Publicado: (2010)

Iron out KRAS-driven cancer
por: Lei, Guang, et al.
Publicado: (2022)

Clinical-Pathological Correlation of KRAS Mutation Status in Metastatic Colorectal Adenocarcinoma
por: Ribeiro, Karen Bento, et al.
Publicado: (2013)

Roles for the IKK-Related Kinases TBK1 and IKKε in Cancer
por: Durand, Joel K., et al.
Publicado: (2018)

KRAS-driven ROS promote malignant transformation
por: Suh, Yongjoon, et al.
Publicado: (2015)

Twists and turns in Kras-driven tumor initiation
por: Maru, Yoshiaki, et al.
Publicado: (2021)

Nf1 loss promotes Kras‐driven lung adenocarcinoma and results in Psat1‐mediated glutamate dependence
por: Wang, Xiaojing, et al.
Publicado: (2019)

PPDPF Promotes the Development of Mutant KRAS‐Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1
por: Ni, Qian‐Zhi, et al.
Publicado: (2022)

Skyldig! - Ikke skyldig! /
por: Coppee, François, 1842-1908. [from old catalog]
Publicado: (1898)

Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas
por: Baldelli, Elisa, et al.
Publicado: (2021)

IKKα and IKKβ Regulation of DNA Damage-Induced Cleavage of Huntingtin
por: Khoshnan, Ali, et al.
Publicado: (2009)

EGFR and KRAS Mutations in Patients With Adenocarcinoma of the Lung
por: Jang, Tae Won, et al.
Publicado: (2009)

Critical requirement of SOS1 for tumor development and microenvironment modulation in KRAS(G12D)-driven lung adenocarcinoma
por: Baltanás, Fernando C., et al.
Publicado: (2023)

EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma
por: Chalela, Roberto, et al.
Publicado: (2021)

KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
por: Gurreri, Enrico, et al.
Publicado: (2023)

Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors
por: Prescott, Jack A., et al.
Publicado: (2018)

EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma
por: Szablewski, Vanessa, et al.
Publicado: (2013)

IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines
por: Song, Na-Young, et al.
Publicado: (2022)

Behind the Wheel of Epithelial Plasticity in KRAS-Driven Cancers
por: Arner, Emily N., et al.
Publicado: (2019)

Brown Tumors Belong to the Spectrum of KRAS-driven Neoplasms
por: Turek, Daniel, et al.
Publicado: (2022)

Jorden går ikke under
Publicado: (2008)

KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
por: Yu, Shuang-Ni, et al.
Publicado: (2016)

Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma
por: Grinshpun, Albert, et al.
Publicado: (2019)

Apatinib in the treatment of advanced lung adenocarcinoma with KRAS mutation
por: Zeng, Da-xiong, et al.
Publicado: (2017)

An unexpected twist to the activation of IKKβ: TAK1 primes IKKβ for activation by autophosphorylation
por: Zhang, Jiazhen, et al.
Publicado: (2014)

TfR1 interacts with the IKK complex and is involved in IKK–NF-κB signalling
por: Kenneth, Niall S., et al.
Publicado: (2012)

Selective autophagic degradation of the IKK complex in Drosophila is mediated by Kenny/IKKγ to control inflammation
por: Jacomin, Anne-Claire, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rligb08rt8vp1dcm4f84spm2fv